Histopathological features and demographics in chronic hepatitis C infection
No subject received interferon therapy before liver biopsy.
Patients with Chronic Hepatitis C (n = 63) | |
|---|---|
| Age (years) | 53 ± 10 |
| Sex (male/female) | 34/29 |
| Smoking (n) | 20 |
| Alcohol (n) | 21 |
| Major medications | |
| Glycyrrhizic acid/ursodeoxycholic acid | F1 (6), F2 (2), F3 (4) |
| Amlodipine/nicardipine/atenolol | F1 (5), F2 (2), F3 (2) |
| Brotizolam/alprazolam/triazolam | F1 (4), F2 (1), F3 (0) |
| Glimepiride/nateglinide | F1 (4), F2 (1), F3 (1) |
| Pathological class | |
| Fibrosis staging (n) | F0 (0), F1 (35), F2 (11), F3 (17), F4 (0) |
| Inflammation grading (n) | A0 (0), A1 (38), A2 (25), A3 (0) |